Prescriptions with warning notes about cost.
·
4 Min Read

Patients give voice to call for drug pricing transparency

A new website aims to bring needed transparency to skyrocketing drug prices and give patients the chance to tell their stories about how rising prices are affecting their health and finances.

Behavioral Health
1 Min Read

Join the campaign to promote transparency in drug prices

Discover the AMA grassroots campaign to promote transparency in drug prices.

Behavioral Health
·
2 Min Read

AMA launches campaign to hear patients stories on rising drug prices

The AMA launched TruthInRx.org, a website that aims to bring much-needed transparency to skyrocketing prescription drug prices.

Press Releases
Dish being held up against superbug description
·
4 Min Read

Identifying superbugs: HHS offers $20 million for faster tests

To combat superbugs, HHS recently announced a prize competition for new rapid, point-of-care laboratory diagnostic tests for drug-resistant bacteria.

Behavioral Health
·
2 Min Read

AMA applauds UN for taking step to combat antimicrobial resistance

"Statement attributable to: Andrew W. Gurman, M.D. President, American Medical Association"

Press Releases
·
1 Min Read

AMA urges EpiPen manufacturer to rein in exorbitant costs

"Statement attributable to: Andrew W. Gurman, M.D. President, American Medical Association"

Press Releases
·
2 Min Read

Physicians confront the rise of “smart drugs”

Safety concerns generated by a growing use of nootropics prompted the AMA to adopt new policy discouraging the nonmedical use of these prescription drugs for cognitive enhancement in healthy individuals.

Behavioral Health
·
2 Min Read

AMA confronts the rise of nootropics

Responding to the growing personal use of nootropics, AMA physicians today adopted policy to discourage nonmedical use of drugs for cognitive enhancement.

Press Releases
National Advocacy Conference panel
·
5 Min Read

Experts explain high drug prices, offer solutions

Addressing the rising cost of prescription drugs, 3 experts in the pharmaceuticals field discuss marketplace trends affecting drug spending and pricing. They also discuss solutions to address drug prices and availability.

Behavioral Health